Care of the Patient Who Misuses Drugs

  • Jerome E. Schulz


Patients who misuse drugs are commonly seen by family physicians in the clinic, emergency room, and hospital. This chapter discusses commonly misused “street” drugs, with the emphasis on the most frequent medical complications, presenting complaints, symptoms, and treatment. The last portion of the chapter discusses guidelines for the care of patients in drug addiction recovery programs. Almost all patients who misuse illicit drugs also misuse alcohol and tobacco, and those medical complications are discussed elsewhere in this book (see Chapters 8, 59, 83).


Misuse Alcohol Human Immunodeficiency Virus Disease Misuse Drug Urine Drug Screen Body Packer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schulz JE. Illicit drugs of abuse. Prim Care 1993;20:221–30.PubMedGoogle Scholar
  2. 2.
    Goldfrank LR, Hoffman RS. The cardiovascular effects of cocaine. Ann Emerg Med 1991;20:165–75.PubMedCrossRefGoogle Scholar
  3. 3.
    Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of labetolol on cocaine-induced coronary vasoconstriction in humans. Am J Med 1993;94:608–10.PubMedCrossRefGoogle Scholar
  4. 4.
    Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med 1994;1:330–9.PubMedCrossRefGoogle Scholar
  5. 5.
    McNagny SD, Parker RM. High prevalence of recent cocaine use and the unreliability of patient self-report in an innercity walk-in clinic. JAMA 1992;267:1106–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Trabulsy ME. Cocaine washed out syndrome in a patient with acute myocardial infarction. Am J Emerg Med 1995; 13:538–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Rubin RB, Neugarten J. Cocaine-induced rhabdomyolysis masquerading as myocardial ischemia. Am J Med 1989; 86:551–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Brogan WC, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991;18:581–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Hollander JE, Burstein JL, Hoffman RS, Shih RD, Wilson LD. Cocaine-associated myocardial infarction. Chest 1995;107: 1237–41.PubMedCrossRefGoogle Scholar
  10. 10.
    Hogya PT, Wolfson AB. Chronic cocaine abuse associated with dilated cardiomyopathy. Am J Emerg Med 1991;8: 203–4.CrossRefGoogle Scholar
  11. 11.
    Stevens DC, Campbell JP, Carter JE, Waston WA. Acid-base abnormalities associated with cocaine toxicity in emergency department patients. Clin Toxicol 1994;32:31–39.CrossRefGoogle Scholar
  12. 12.
    Om A, Ellahham S, DiSciascio G. Management of cocaine-induced cardiovascular complications. Am Heart J 1993;125: 469–75.PubMedCrossRefGoogle Scholar
  13. 13.
    Maouhaffel AH, Madu EC, Satmary WA, Fraker TD. Cardiovascular complications of cocaine. Chest 1995;107:1426–34.CrossRefGoogle Scholar
  14. 14.
    Olson KR, Kearney TE, Dyer JE, Benowitz NL, Blanc PD. Seizures associated with poisoning and drug overdose. Am J Emerg Med 1993;11:565–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Mott SH, Packer RJ, Soldin SJ. Neurologic manifestations of cocaine exposure in childhood. Pediatrics 1994;93:557–60.PubMedGoogle Scholar
  16. 16.
    Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr 1986;108: 456–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Cohen HR, Green JR, Crombleholm WR. Peripartum cocaine use: estimating risk of adverse pregnancy outcome. Int J Gynecol Obstet 1991;35:51–4.CrossRefGoogle Scholar
  18. 18.
    Frassica JJ, Orav EJ, Walsh EP, Lipshultz SE. Arrhythmias in children prenatally exposed to cocaine. Arch Pediatr Adolesc Med 1994;148:1163–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry 1991;148:1798–811.Google Scholar
  20. 20.
    Haim DY, Lippmann ML, Goldberg SK, Walkenstein MD. The pulmonary complications of crack cocaine. Chest 1995; 107:233–49.PubMedCrossRefGoogle Scholar
  21. 21.
    Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgoignie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med 1988;319:673–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Swart GL, Hargarten SW. Pharmacological therapies for drug and alcohol addictions in emergency settings. In: Miller NS, Gold MS, editors. Pharmacological therapies for drug and alcohol addictions. New York: Marcel Dekker, 1994:341–72.Google Scholar
  23. 23.
    Smith DA, Leake L, Loflin JR, Yealy DM. Is admission after intravenous heroin overdose necessary? Ann Emerg Med 1992;21:1326–30.PubMedCrossRefGoogle Scholar
  24. 24.
    Levy M, Spino M. Neonatal withdrawal syndrome: associated drugs and pharmacological management. Pharmacotherapy 1993;13:202–11.PubMedGoogle Scholar
  25. 25.
    Derlet RW, Hatoum HT, Waters IW, Lord RV. Amphetamine toxicity: experience with 127 cases. J Emerg Med 1989;7: 157–61.PubMedCrossRefGoogle Scholar
  26. 26.
    Packe GE, Garton MJ, Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J 1990;4:23–4.CrossRefGoogle Scholar
  27. 27.
    Aron CK. Sympathomimetics. Emerg Med Clin North Am 1990;8:513–26.Google Scholar
  28. 28.
    Mathias R. Student’s use of marijuana, other illicit drugs, and cigarettes continued to rise in 1995. NIDA Notes 1996; Jan/Feb.Google Scholar
  29. 29.
    Gold MS. Marijuana. In: Miller NS, editor. Principles of addiction medicine. Chevy Chase: ASAM, 1994:2.8:1–6.Google Scholar
  30. 30.
    Kulig K. LSD. Emerg Med Clin North Am 1990;8:551–8.Google Scholar
  31. 31.
    Miller NS, Gold MS. Organic solvent and aerosol abuse. Am Fam Physician 1991;44:183–9.PubMedGoogle Scholar
  32. 32.
    Product information. Research Triangle, NC: Glaxo Wellcome,1995.Google Scholar
  33. 33.
    Kitchen VS, Skinner C, Ariygohi K, et al. Safety and activity of saquinavir in HIV infection. Lancet 1995;345:952–5.PubMedCrossRefGoogle Scholar
  34. 34.
    MacConnell TJ, Stanners AJ. Torsades de pointes complicating treatment with terfenadine. BMJ 1991;302:1469.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Jerome E. Schulz

There are no affiliations available

Personalised recommendations